A promising approach to treatment of chronic lung diseases is the intratracheal delivery of pluripotent stem cell derived alveolar-like macrophages (PSC-ALMs) into the injured lung to facilitate repair of damaged tissue. This treatment is hindered by the inability to assess where in the lung these cells end up. Here, hyperpolarized Xe-129 MRI paired with iron-labeled cells was used to demonstrate a proof-of-concept visualization of cells introduced in the lungs of rats. Signal hypointensities were observed at least one hour after instillation of approximately two million labeled cells in one rat, compared to instillation of control solutions in separate rats.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords